Skip to content
lifestyle.nextmentors.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Castle Biosciences, Inc.
Castle Biosciences to Participate in Upcoming Investor Conferences
August 20, 2026
Castle Biosciences Approved for Dual Listing on Nasdaq Texas
August 17, 2026
Castle Biosciences Reports Second Quarter 2026 Results
July 30, 2026
Castle Biosciences’ TissueCypher® Test Surpasses 100,000 Orders, Advancing Precision Risk Assessment for Patients with Barrett’s Esophagus
June 16, 2026
Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference
May 20, 2026
Castle Biosciences’ AdvanceAD-Tx™ Test Receives 2026 MedTech Breakthrough Award for Genomics Innovation
May 12, 2026
Castle Biosciences Reports First Quarter 2026 Results
May 8, 2026
New Data at DDW 2026 Show TissueCypher® Testing Improves Risk Stratification and Drives Risk-Aligned Management in Barrett’s Esophagus
May 5, 2026
Castle Biosciences Supports Nationwide Patient Advocacy and Screening Initiatives to Celebrate Skin Cancer Awareness Month
May 5, 2026
Castle Biosciences to Present New Data Demonstrating DecisionDx®-Melanoma’s Ability to Identify Patients with Greater Risk of Recurrence and Poor Outcomes Within Early-Stage Melanoma at EADO and ACMS
April 28, 2026
1
2
3
Next Page
→